Cita APA (7a ed.)

Sato, M., Nakai, Y., Nakata, W., Yoshida, T., Hatano, K., Kawashima, A., . . . Nonomura, N. (2013). EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome. Public Library of Science (PLoS).

Cita Chicago Style (17a ed.)

Sato, Mototaka, et al. EMMPRIN Promotes Angiogenesis, Proliferation, Invasion and Resistance to Sunitinib in Renal Cell Carcinoma, and Its Level Predicts Patient Outcome. Public Library of Science (PLoS), 2013.

Cita MLA (8a ed.)

Sato, Mototaka, et al. EMMPRIN Promotes Angiogenesis, Proliferation, Invasion and Resistance to Sunitinib in Renal Cell Carcinoma, and Its Level Predicts Patient Outcome. Public Library of Science (PLoS), 2013.